Although the precise molecular target through which SEN461 exerts its anti-tumor activity has yet to be determined, similarities at the phenotypic level coupled with discrepancies at the molecular level (e.g. down regulation of c-Myc protein level) between XAV939 and SEN461 suggest that they act similarly but not identically. This evidence concerns the gene MYC and neoplasm.